Search

Your search keyword '"Matias-Guiu, Xavier"' showing total 1,503 results

Search Constraints

Start Over You searched for: Author "Matias-Guiu, Xavier" Remove constraint Author: "Matias-Guiu, Xavier"
1,503 results on '"Matias-Guiu, Xavier"'

Search Results

2. Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application

7. Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE

8. Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup

9. Occupational exposure to pesticides and endometrial cancer in the Screenwide case-control study

10. AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin-dependent cell migration

11. Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer

12. Cost-effectiveness analysis of molecular testing in minimally invasive samples to detect endometrial cancer in women with postmenopausal bleeding

14. NaroNet: Discovery of tumor microenvironment elements from highly multiplexed images

16. Targeted Next Generation Sequencing of a Custom Capture Panel to Target Sequence 112 Cancer Related Genes in Breast Cancer Tumors ERBB2 Positive from Lleida (Spain)

18. Total Effective Xenoestrogen Burden in Serum Samples and Risk of Endometrial Cancer in the Spanish Screenwide Case-Control Study

20. Myosin Vb as a tumor suppressor gene in intestinal cancer

21. Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer

22. Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome

23. Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors

27. Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study

28. Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

32. ROLE OF cfDNA AND ctDNA TO IMPROVE THE RISK STRATIFICATION AND THE DISEASE FOLLOW-UP IN PATIENTS WITH ENDOMETRIAL CANCER: TOWARDS THE CLINICAL APPLICATION

33. Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum

35. M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients

36. Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes

38. Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer

42. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma

43. SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade

46. Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer

49. Ovarian cancer relies on the PDGFRβ–fibronectin axis for tumorsphere formation and metastatic spread

50. CD73 controls Myosin II–driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells

Catalog

Books, media, physical & digital resources